How the doctor can counter commercial bias in the dissemination of pharmacotherapeutic knowledgeCARPENTER, William T.The Journal of nervous and mental disease. 2002, Vol 190, Num 9, pp 593-596, issn 0022-3018Article

Identifying unmet therapeutic domains in schizophrenia patients : The early contributions of wayne fenton from chestnut lodge : Progress on NIMH initiativesMCGLASHAN, Thomas H; CARPENTER, William T.Schizophrenia bulletin. 2007, Vol 33, Num 5, pp 1086-1092, issn 0586-7614, 7 p.Article

Lessons to Take Home From CATIE : Implications of CATIECARPENTER, William T; BUCHANAN, Robert W.Psychiatric services (Washington, D.C.). 2008, Vol 59, Num 5, pp 523-525, issn 1075-2730, 3 p.Article

Will the Kraepelinian Dichotomy Survive DSM-V?FISCHER, Bernard A; CARPENTER, William T.Neuropsychopharmacology (New York, NY). 2009, Vol 34, Num 9, pp 2081-2087, issn 0893-133X, 7 p.Article

The Evolution of Drug Development in Schizophrenia : Past Issues and Future Opportunities : Institue of Medicine Forum on Drug Discovery, Development, and TranslationCARPENTER, William T; KOENIG, James I.Neuropsychopharmacology (New York, NY). 2008, Vol 33, Num 9, pp 2061-2079, issn 0893-133X, 19 p.Article

Optimistic bias in the perception of personal risk : Patterns in schizophreniaPRENTICE, Kristen J; GOLD, James M; CARPENTER, William T et al.The American journal of psychiatry. 2005, Vol 162, Num 3, pp 507-512, issn 0002-953X, 6 p.Article

A comparison of symptom provocation procedures in psychiatry and other areas of medicine : Implications for their ethical use in researchAVILA, Matthew T; CONLEY, Robert R; CARPENTER, William T et al.Biological psychiatry (1969). 2001, Vol 50, Num 7, pp 479-486, issn 0006-3223Article

At issue : A model for academic/industry collaborationCARPENTER, William T; KOENIG, James I; BILBE, Graeme et al.Schizophrenia bulletin. 2004, Vol 30, Num 4, pp 997-1004, issn 0586-7614, 8 p.Article

First-episode schizophrenia : A focus on pharmacological treatment and safety considerationsKELLY, Deanna L; CONLEY, Robert R; CARPENTER, William T et al.Drugs (Basel). 2005, Vol 65, Num 8, pp 1113-1138, issn 0012-6667, 26 p.Article

The deficit syndrome in schizophrenia: implications for the treatment of negative symptomsARANGO, Celso; BUCHANAN, Robert W; KIRKPATRICK, Brian et al.European psychiatry. 2004, Vol 19, Num 1, pp 21-26, issn 0924-9338, 6 p.Article

The Declaration of Helsinki and clinical trials: A focus on placebo-controlled trials in schizophreniaCARPENTER, William T; APPELBAUM, Paul S; LEVINE, Robert J et al.The American journal of psychiatry. 2003, Vol 160, Num 2, pp 356-362, issn 0002-953X, 7 p.Article

Treatment of schizophrenia negative symptoms : Future prospects : Negative symptomsERHART, Stephen M; MARDER, Stephen R; CARPENTER, William T et al.Schizophrenia bulletin. 2006, Vol 32, Num 2, pp 234-237, issn 0586-7614, 4 p.Article

Testing trait depression as a potential clinical domain in schizophreniaCHIAPPELLI, Joshua; KOCHUNOV, Peter; DERISO, Katherine et al.Schizophrenia research. 2014, Vol 159, Num 1, pp 243-248, issn 0920-9964, 6 p.Article

Neuroplasticity and schizophreniaFROST, Douglas O; TAMMINGA, Carol A; MEDOFF, Deborah R et al.Biological psychiatry (1969). 2004, Vol 56, Num 8, pp 540-543, issn 0006-3223, 4 p.Article

Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition taskLAHTI, Adrienne C; HOLCOMB, Henry H; MEDOFF, Deborah R et al.The American journal of psychiatry. 2001, Vol 158, Num 11, pp 1797-1808, issn 0002-953XArticle

Multimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophreniaKOCHUNOV, Peter; CHIAPPELLI, Joshua; SAMPATH, Hemalatha et al.Psychiatry research. Neuroimaging. 2014, Vol 223, Num 2, pp 148-156, issn 0925-4927, 9 p.Article

Lack of Use in the Literature From the Last 20 Years Supports Dropping Traditional Schizophrenia Subtypes From DSM-5 and ICD-11BRAFF, David L; RYAN, James; RISSLING, Anthony J et al.Schizophrenia bulletin. 2013, Vol 39, Num 4, pp 751-753, issn 0586-7614, 3 p.Article

Participants With Schizophrenia Retain the Information Necessary for Informed Consent During Clinical TrialsFISCHER, Bernard A; McMAHON, Robert P; MEYER, Walter A et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 6, pp 622-627, issn 0160-6689, 6 p.Article

Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophreniaSTRAUSS, Gregory P; ALLEN, Daniel N; MISKI, Pinar et al.Schizophrenia research. 2012, Vol 135, Num 1-3, pp 134-138, issn 0920-9964, 5 p.Article

Functional impairment in people with schizophrenia: Focus on employability and eligibility for disability compensation : Schizophrenia and disability compensationHARVEY, Philip D; HEATON, Robert K; CARPENTER, William T et al.Schizophrenia research. 2012, Vol 140, Num 1-3, pp 1-8, issn 0920-9964, 8 p.Article

Mazindol treatment of negative symptomsCARPENTER, William T; BREIER, Alan; BUCHANAN, Robert W et al.Neuropsychopharmacology (New York, NY). 2000, Vol 23, Num 4, pp 365-374, issn 0893-133XArticle

Diagnosis of schizophrenia: Consistency across information sources and stability of the condition : Schizophrenia and disability compensationHARVEY, Philip D; HEATON, Robert K; CARPENTER, William T et al.Schizophrenia research. 2012, Vol 140, Num 1-3, pp 9-14, issn 0920-9964, 6 p.Article

Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophreniaHONG, L. Elliot; WONODI, Ikwunga; AVILA, Matthew T et al.American journal of medical genetics. 2005, Vol 136B, Num 1, pp 8-11, issn 0148-7299, 4 p.Article

Page / 2